Companhia Brasileira DE Distribuicao ADR (CBD)

$3.26 0.12 (3.79%)

11:31 EDT CBD Stock Quote Delayed 30 Minutes

7 Retail Stocks to Keep Your Distance From

By Louis Navellier and the InvestorPlace Research Staff Apr 6, 2020

The retail environment is changing once again. These seven companies are having trouble adjusting.

The Daily Cut: Don’t Let the FDA Scare You Away From CBD

4 Key Players Just Held a Marijuana Summit

Lift a Glass to Legal Cannabis’ Next Big Trend — and Opportunity

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 373,934

Day's Range $3.18 - $3.27

52-Week Range $2.73 - $6.02

Dividend & Yield N/A (N/A)

CBD Stock Predictions, Articles, and Companhia Brasileira DE Distribuicao ADR News

From InvestorPlace
From the Web

This $2 Billion Cannabis Catalyst Is Just Days Away

By InvestorPlace Research Staff Oct 14, 2019

Cannabis companies are on the verge of ushering in a whole new category of products and welcoming a brand-new group of consumers.

Square (SQ Stock) Disrupts Yet Another Industry

By InvestorPlace Research Staff Oct 9, 2019

Square is a dream come true for small business owners. And, as of Thursday, that’s now true for a whole new (and red-hot) market: cannabidiol (CBD).

Cannabis Stocks: Be Ready for the Next Catalyst

By InvestorPlace Research Staff Oct 1, 2019

A new bill making its way through Congress is set to upend this outdated legal regime and usher in the next wave of growth in cannabis stocks.

Cannabis Stocks: We’ve Collected our First Cannabis Cash!

By InvestorPlace Research Staff Oct 1, 2019

Matt McCall's strategy harnesses the growth of cannabis stocks and combines it with the income available from covered calls.

Marijuana Stocks: How to Profit Twice

By InvestorPlace Research Staff Sep 30, 2019

Use this proven strategy to boost your returns in an absolutely massive investing theme: marijuana legalization.

Cannabis Stocks: How to Earn a 100% Yield Next Year … No Joke

By InvestorPlace Research Staff Sep 25, 2019

Thanks to a once-in-a-decade anomaly in the business world, there’s currently an investment offering 100%+ annual yields in the cannabis sector.

The ‘Secret’ Ingredient Set to Send Marijuana Stocks Soaring

By InvestorPlace Research Staff Sep 16, 2019

Marijuana companies are right now hitting the investing sweet spot. Here's why now is the time to buy.

Marijuana Stocks: One Chart Says Now Is The Time to Buy

By InvestorPlace Research Staff Aug 29, 2019

Don’t get caught in the herd of doubters running for the hills. The long-term story for marijuana stocks is intact, and today is the day to buy.

Aurora Cannabis Doubles Down on U.S. CBD Market

By Theodore Kim Aug 22, 2019

Among marijuana stocks, Aurora Cannabis stock has been doing some of the best work at making smart acquisitions and investing in the future.

Major Headlines Mean Opportunities for Smart Investors

By InvestorPlace Research Staff Aug 19, 2019

Last week was full of major headlines, Matt McCall takes a look.

CBD Oil: The True Power of a Consumer Craze

By InvestorPlace Research Staff Jun 19, 2019

Whether you have tried CBD oil or not, millions of people have. I think you’re going to like the numbers on this one. Here’s the latest on the CBD craze.

7 Stocks to Buy that Lost 10% Last Week

By Will Ashworth, InvestorPlace Contributor May 15, 2019

After the pain in the markets last week, there are some great stocks to buy that are on a 10% or more discount.

6 Signs That Marijuana Legalization is Closer Than You Think

By InvestorPlace Research Staff May 9, 2019

Based on the facts, news, and trends – not a gut feeling for or against marijuana – I expect legalization soon. And I've got six reasons why.

7 Catalysts That Will Send Marijuana Stocks Soaring in 2019

By InvestorPlace Research Staff Apr 9, 2019

Looking back at 2018, we thought that was a big year for marijuana stocks…but 2019 will be HUGE as these remaining "dominos" fall down.

Marijuana Stocks Go Mainstream As CBD Jumps to CVS and Walgreens

By InvestorPlace Research Staff Mar 28, 2019

I’ve long thought that marijuana's non-psychoactive cousin, cannabidiol (CBD), could be the real growth opportunity. But don’t take my word for it. CVS and Walgreens apparently see the same thing.